Chiesi is an international company based in Parma, with more than 85 years of experience, and a strong focus on research, development, production and commercialization of innovative medicines in the Respiratory, Special Care and Rare Disease Therapeutic Areas.
We are the largest Global Pharmaceutical Group to be awarded with BCorp Certification, a recognition of highest verified standards of social and environmental performance, transparency and accountability.
Our commitment in Solid Organ Transplantation started with the commercialization of Envarsus® in EU, a once-daily tacrolimus formulation with an improved pharmacokinetic profile, indicated for the prophylaxis and treatment of transplant rejection in adult kidney and liver allograft recipients.
Chiesi Farmaceutici S.p.A.
Via Palermo 26/A